Literature DB >> 15245821

P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin.

Ciaran M Brady1, Apostolos Apostolidis, Yiangos Yiangou, Preston A Baecker, Anthony P Ford, Alex Freeman, Thomas S Jacques, Clare J Fowler, Praveen Anand.   

Abstract

OBJECTIVES: The ATP-gated purinergic receptor P2X3 is expressed by small diameter sensory neurons and has been identified in normal and neurogenic human bladder suburothelial fibres. Animal models have shown that ATP is released by the urothelium during bladder distension, suggesting a mechanosensory role for P2X3 receptors in normal bladder function. Successful treatment of spinal neurogenic detrusor overactivity (NDO) with intravesical resiniferatoxin (RTX), which partly acts on suburothelial C fibres, provides evidence for the emergence of a C fibre-mediated spinal reflex. The aim of this study was to investigate the possible role of P2X3-positive innervation in this pathological voiding reflex by comparing suburothelial P2X3 immunoreactivity of controls and in patients with NDO before and after intravesical RTX.
METHODS: Bladder biopsies were obtained from 8 controls and 20 patients with refractory NDO enrolled in a trial of intravesical RTX. P2X3 nerve fibre density and intensity were studied in the specimens by immunohistochemistry.
RESULTS: P2X3-IR nerve fibres were significantly increased in patients with NDO compared to controls (p=0.014). Thirteen patients had pre- and post-RTX biopsies available for immunohistochemistry; 5 of them responded clinically and 8 were non-responders. In the 5 patients who responded to RTX, there was a significant decrease in P2X3-positive fibres (p=0.032), whereas in non-responders, P2X3-IR nerve fibre density did not change significantly.
CONCLUSIONS: In patients with NDO, the numbers of P2X3-IR nerve fibres were increased in the suburothelium. There was a significant decrease in P2X3 immunoreactivity in responders to RTX, indicating a potential pathophysiological role for the P2X3 expressing fibres.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245821     DOI: 10.1016/j.eururo.2003.12.017

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  44 in total

Review 1.  Mechanisms of disease: involvement of the urothelium in bladder dysfunction.

Authors:  Lori A Birder; William C de Groat
Journal:  Nat Clin Pract Urol       Date:  2007-01

Review 2.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

Review 3.  Integrated control of lower urinary tract--clinical perspective.

Authors:  Clare J Fowler
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Expression and function of rat urothelial P2Y receptors.

Authors:  Bikramjit Chopra; Joel Gever; Stacey R Barrick; Ann T Hanna-Mitchell; Jonathan M Beckel; Anthony P D W Ford; Lori A Birder
Journal:  Am J Physiol Renal Physiol       Date:  2008-01-23

Review 5.  Changes in afferent activity after spinal cord injury.

Authors:  William C de Groat; Naoki Yoshimura
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

6.  Beyond neurons: Involvement of urothelial and glial cells in bladder function.

Authors:  Lori A Birder; Amanda S Wolf-Johnston; Manjul K Chib; Charles A Buffington; James R Roppolo; Ann T Hanna-Mitchell
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

7.  Delayed contrast-enhanced MRI to localize Botox after cystoscopic intravesical injection.

Authors:  Mazen Alsinnawi; William Torreggiani; Mazher Sheikh; Arun Thomas; John Donnellan; Robert Flynn; T E D Mcdermott; John Thornhill
Journal:  Int Urol Nephrol       Date:  2015-04-19       Impact factor: 2.370

Review 8.  Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury.

Authors:  Rizwan Hamid; Marcio Augusto Averbeck; Humberto Chiang; Arturo Garcia; Riyad T Al Mousa; Seung-June Oh; Anita Patel; Mauricio Plata; Giulio Del Popolo
Journal:  World J Urol       Date:  2018-05-11       Impact factor: 4.226

9.  Sodium channel Na v 1.7 immunoreactivity in painful human dental pulp and burning mouth syndrome.

Authors:  Kiran Beneng; Tara Renton; Zehra Yilmaz; Yiangos Yiangou; Praveen Anand
Journal:  BMC Neurosci       Date:  2010-06-08       Impact factor: 3.288

Review 10.  Purinergic mechanosensory transduction and visceral pain.

Authors:  Geoffrey Burnstock
Journal:  Mol Pain       Date:  2009-11-30       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.